All Immunology articles – Page 4
-
NewsScientists probe honeybee antiviral defense mechanisms
Scientists are investigating honeybee antiviral defense mechanisms with the goal of developing strategies to reduce honeybee colony deaths.
-
NewsWhy you shouldn’t scratch an itchy rash: New study explains
New research uncovers how scratching aggravates inflammation and swelling in a mouse model of a type of eczema called allergic contact dermatitis.
-
NewsAntibody treatment prevents severe bird flu in monkeys
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, a new study reports.
-
NewsResearchers in Brazil discover a gene that may afford protection against COVID-19
During the pandemic, health worker Maria Tereza Malheiros Sapienza’s curiosity was aroused by her immunity to SARS-CoV-2, even though her husband was infected twice. A new study reveals that an overexpression of IFIT3 protein was responsible.
-
NewsStudy yields new insights into the immunomodulatory properties of russula polysaccharides
A new study investigates the structural characteristics and immunomodulatory activities of polysaccharides extracted from Russula vinosa Lindblad using KOH, highlighting the potential of these polysaccharides for applications in pharmaceuticals and functional foods.
-
NewsCould faecal microbiota transplantation help patients heal after stem cell transplantation?
A study, from a part of an ongoing clinical trial, has reported the safety of oral faecal microbiota transplantation (FMT) to help patients recover from the loss of gut microbiome after allogeneic stem cell transplantation for blood cancers.
-
NewsMicrobial therapy offers new hope for vitiligo patients
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new pre-clinical study in mice.
-
NewsWhite blood cell count could predict severity of COVID-19 symptoms
A new study suggests that a readily available and inexpensive clinical marker of inflammation could be key in predicting debilitating COVID outcomes in postmenopausal women.
-
NewsA new vaccine approach could help combat future coronavirus pandemics
Researchers are able to create a mosaic nanoparticle vaccine - mosaic-8, based on the sarbecovirus receptor-binding proteins (RBDs), which would help combatting SARS-CoV-2 variants and other coronavirus subtypes.
-
NewsA therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
-
NewsViruses and the human cell: The evolutionary arms race
Researchers have discovered a unique genetic mechanism that provides cells with rapid and efficient protection against viruses. The findings could lead to the development of new therapeutics.
-
NewsHepatitis B is a problem for a growing number of patients on immunosuppressive medications
The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs.
-
NewsAntiviral protein causes genetic changes implicated in Huntington’s disease progression
A new study shows APOBEC enzymes, which normally help fight viral infections by mutating viral DNA, are unusually active in the brains of Huntington’s patients.
-
NewsNew research reveals how location influences how our immune system fights disease
Researchers have revealed how cells known as tissue-resident memory CD8 T cells play unique and specialized roles based on where they are located within the small intestine, providing a local first line of defense against re-infection.
-
NewsScientists discover how the gut modulates the development of inflammatory conditions
Scientists have discovered how gut bacteria that cross a weakened intestinal barrier induce changes in bone marrow that strengthen the immune response.
-
NewsDihydroartemisinin inhibits T cell activation in people living with HIV with incomplete immune reconstitution in vitro
A new study provides insights into the biological mechanisms underlying incomplete immune reconstitution in people with HIV and supports dihydroartemisinin’s potential as a therapeutic agent.
-
NewsHuman papillomavirus infection kinetics revealed in new longitudinal study
Non-persistent human papillomavirus (HPV) infections are characterized by a sharp increase in viral load followed by a long plateau, according to a new study.
-
NewsValneva reports high sustained immune response in adolescents one year after Chikungunya Vaccine
Valneva SE, a specialty vaccine company, has reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, which showed a sustained 98.3% sero-response rate one-year after single vaccination.
-
NewsChain reaction: HIV vaccines can lead to antibodies against antibodies
Scientists have discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus—knowledge that could lead to better vaccines.
-
NewsNew research provides insight into reduced COVID-19 vaccine efficacy in lupus patients
A recent study provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases, highlighting that lupus patients may require tailored vaccination strategies.